Global Immunoassay Analyzers Market Size To Exceed USD 10.75 Billion by 2035| CAGR of 3.91%
Category: HealthcareAccording to a research report published by Spherical Insights & Consulting, The Global Immunoassay Analyzers Market Size is Expected To Grow from USD 7.05 Billion in 2024 to USD 10.75 Billion by 2035, at a CAGR of 3.91% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Immunoassay Analyzers Market Size, Share, and COVID-19 Impact Analysis, By Product (Chemiluminescence Immunoassays (CLIA), Fluorescence Immunoassays (FIA), Radioimmunoassay, Enzyme-Linked Immunoassay, and Consumables and Accessories), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Infectious Disease Testing, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/immunoassay-analyzers-market
The immunoassay analyzers market refers to the industry emphasizing the manufacturing, sales, and use of automated instruments that perform immunoassays. Immunoassay analyzers are used for identifying and detecting the concentration of specific substances in a sample, often used in clinical diagnostics, drug discovery, drug monitoring, and food testing. An increasing demand for innovative solutions, encouraging companies to develop more advanced and effective diagnostic technologies in immunoassay analyzers. Technological advancements and increasing efforts to enhance the accuracy of diagnostic results are providing market growth opportunities. An increasing prevalence of chronic and infectious diseases is responsible for driving the demand for immunoassay analyzers for diagnosis and monitoring treatment, which thereby propels the immunoassay analyzers market. Further, increasing investments in the pharma and biotech sectors, as well as strategic collaborations among companies for promoting innovation, are supporting market growth. On the contrary, the increased initial costs and expenses on immunoassay analyzers, as well as the lack of a skilled workforce, are challenging the market growth.
The consumables and accessories segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product, the immunoassay analyzers market is divided into chemiluminescence immunoassays (CLIA), fluorescence immunoassays (FIA), radioimmunoassay, enzyme-linked immunoassay, and consumables and accessories. Among these, the consumables and accessories segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Continuous innovation of consumables, along with an increasing adoption of immunoassay analyzers for diagnosis, is propelling the market growth in the consumables and accessories segment.
The infectious disease testing segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the immunoassay analyzers market is divided into therapeutic drug monitoring, oncology, cardiology, infectious disease testing, and others. Among these, the infectious disease testing segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Immunoassay analyzers are used for detecting specific antibody classes in serum, plasma, or CSF, or detecting antigens from the samples. An increasing need for efficient diagnostic solutions is propelling the market in the infectious disease testing segment.
North America is expected to hold the majority share of the global immunoassay analyzers market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global immunoassay analyzers market during the forecast period. An expanding application of immunoassays, with the growing prevalence of cancer and cardiovascular disease, is driving the immunoassay analyzers market. Further, the trend towards AI integration and automation in diagnostic platforms aids in promoting market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global immunoassay analyzers market during the forecast period. This is attributed to the rapid rise in demand for efficient diagnostics in emerging economies. Companies are developing and launching innovative products for improving early disease detection and treatment, which ultimately drives the market growth.
Major vendors in the global immunoassay analyzers market areSiemens Healthineers AG, BIOMÉRIEUX, Abbott, QuidelOrtho Corporation, Sysmex Corporation, BD, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., DiaSorin S.p.A., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In January 2025, Anbio Biotechnology, a global leader in diagnostics innovation, announced the launch of its Dry Chemiluminescence Immunoassay (CLIA) Solution ADL-1000, a transformative technology designed to deliver rapid, reliable, and cost-effective diagnostic results.
- In July 2024, Beckman Coulter Diagnostics, a clinical diagnostics leader, introduced the new DxC500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer. Beckman Coulter continues to introduce new innovations to address the needs of the entire network with specific solutions for satellite or independent laboratories, as well as core laboratories.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the immunoassay analyzers market based on the below-mentioned segments:
Global Immunoassay Analyzers Market, By Product
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Radioimmunoassay
- Enzyme-Linked Immunoassay
- Consumables and Accessories
Global Immunoassay Analyzers Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Infectious Disease Testing
- Others
Global Immunoassay Analyzers Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?